Harlan Japan Names New President - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Harlan Japan Names New President



Harlan has announced Hiroharu Okochi as president of Harlan Japan.

Okochi will have full profit and loss responsibility as well as overall accountability for all aspects of the Harlan Contract Research Services business tream serving the Japanese chemical, agrochemical, and pharmaceutical markets.

Prior to joining Harlan, Okochi was responsible for sales and business development of Covance central laboratory services to Japanese pharmaceutical companies. He also held research positions at Shin Nippon Biomedical Laboratories, including the position of general manager of SNBL’s Cambodia subsidiary, where he was responsible for production control and negotiating with the Cambodian government.

Source: Harlan Japan

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
29%
Oversee medical treatment of patients in the US.
11%
Provide treatment for patients globally.
7%
All of the above.
46%
No government involvement in patient treatment or drug development.
7%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics

Click here